Evidence map›Paper›PMID 30385731›Full record

Observational studyJCI insight2018

Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.

Terence E Ryan, Dean J Yamaguchi, Cameron A Schmidt, Tonya N Zeczycki, Saame Raza Shaikh, Patricia Brophy, Thomas D Green, Michael D Tarpey, Reema Karnekar, Emma J Goldberg and 6 more

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Sarcopenia and peripheral arterial disease: a systematic review.Journal of cachexia, sarcopenia and muscle · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Terence E RyanDepartment of Physiology.
Dean J YamaguchiDepartment of Cardiovascular Sciences.
Cameron A SchmidtDepartment of Physiology.
Tonya N ZeczyckiEast Carolina Diabetes and Obesity Institute.
Saame Raza ShaikhDepartment of Nutrition, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Patricia BrophyEast Carolina Diabetes and Obesity Institute.
Thomas D GreenDepartment of Physiology.
Michael D TarpeyDepartment of Physiology.
Reema KarnekarDepartment of Physiology.
Emma J GoldbergDepartment of Physiology.
Genevieve C SparagnaAnschutz Medical Campus, University of Colorado, Denver, Colorado, USA.
Maria J TorresEast Carolina Diabetes and Obesity Institute.
Brian H AnnexDivision of Cardiovascular Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
P Darrell NeuferDepartment of Physiology.
Espen E SpangenburgDepartment of Physiology.
Joseph M McClungDepartment of Physiology.
East Carolina University · USCardiovascular Research Center · BRUniversity of Colorado Anschutz Medical Campus · USUniversity of North Carolina at Chapel Hill · USUniversity of Virginia · US

Funding

A Bioengineering Approach to Gene Therapy for Peripheral Arterial DiseaseR01HL116455 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H, FRENCH, BRENT A · 2014 to 2017
$2.7M
Genetic Determinants of Limb Pathology in Peripheral Artery DiseaseR01HL125695 · NHLBI · EAST CAROLINA UNIVERSITY · PI MCCLUNG, JOSEPH MATTHEW · 2015 to 2019
$1.9M
BRCA1 is necessary for optimal skeletal muscle functionR01AR066660 · NIAMS · EAST CAROLINA UNIVERSITY · PI SPANGENBURG, ESPEN E · 2015 to 2019
$1.6M
MicroRNA 93 in Peripheral Arterial DiseaseR01HL121635 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H · 2014 to 2017
$1.6M
Mitochondrial respirasomes in acute coronary syndromesR01HL123647 · NHLBI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI HULVER, MATTHEW W, SHAIKH, SAAME R · 2015 to 2018
$1.4M
Peripheral endothelial and muscle cell pathology in cardiovascular diseaseR00HL103797 · NHLBI · EAST CAROLINA UNIVERSITY · PI MCCLUNG, JOSEPH MATTHEW · 2014 to 2016
$744k
The Role of Skeletal Muscle Mitochondria in Peripheral Arterial DiseaseF32HL129632 · NHLBI · EAST CAROLINA UNIVERSITY · PI RYAN, TERENCE E · 2016 to 2017
$99k
NHLBI NIH HHS F32 HL129632NHLBI NIH HHS R00 HL103797NHLBI NIH HHS R01 HL116455NHLBI NIH HHS R01 HL121635NHLBI NIH HHS R01 HL123647NHLBI NIH HHS R01 HL125695NIAMS NIH HHS R01 AR066660
6 · The paper itself

Abstract

The most severe manifestation of peripheral arterial disease (PAD) is critical limb ischemia (CLI). CLI patients suffer high rates of amputation and mortality; accordingly, there remains a clear need both to better understand CLI and to develop more effective treatments. Gastrocnemius muscle was obtained from 32 older (51-84 years) non-PAD controls, 27 claudicating PAD patients (ankle-brachial index [ABI] 0.65 ± 0.21 SD), and 19 CLI patients (ABI 0.35 ± 0.30 SD) for whole transcriptome sequencing and comprehensive mitochondrial phenotyping. Comparable permeabilized myofiber mitochondrial function was paralleled by both similar mitochondrial content and related mRNA expression profiles in non-PAD control and claudicating patient tissues. Tissues from CLI patients, despite being histologically intact and harboring equivalent mitochondrial content, presented a unique bioenergetic signature. This signature was defined by deficits in permeabilized myofiber mitochondrial function and a unique pattern of both nuclear and mitochondrial encoded gene suppression. Moreover, isolated muscle progenitor cells retained both mitochondrial functional deficits and gene suppression observed in the tissue. These findings indicate that muscle tissues from claudicating patients and non-PAD controls were similar in both their bioenergetics profile and mitochondrial phenotypes. In contrast, CLI patient limb skeletal muscles harbor a unique skeletal muscle mitochondriopathy that represents a potentially novel therapeutic site for intervention.

Indexed as

AgedAged, 80 and overAnkle Brachial IndexAtherosclerosisCellular MicroenvironmentCross-Sectional StudiesExome SequencingFemaleHumansIntermittent ClaudicationIschemiaMaleMiddle AgedMitochondria, MuscleMuscle, SkeletalPeripheral Arterial DiseaseRNA, MessengerAtherosclerosisCardiovascular diseaseMetabolismSkeletal muscle

Identifiers

PMID30385731
PMCPMC6238738
OpenAlexW2899064175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.